GeoVax Labs Inc. (GOVX)
NASDAQ: GOVX
· Real-Time Price · USD
0.91
-0.01 (-0.55%)
At close: May 15, 2025, 3:59 PM
0.93
2.19%
After-hours: May 15, 2025, 06:39 PM EDT
-0.55% (1D)
Bid | 0.88 |
Market Cap | 13.83M |
Revenue (ttm) | 5.59M |
Net Income (ttm) | -24.5M |
EPS (ttm) | -2.8 |
PE Ratio (ttm) | -0.33 |
Forward PE | -0.9 |
Analyst | Buy |
Ask | 0.93 |
Volume | 190,127 |
Avg. Volume (20D) | 529,893 |
Open | 0.92 |
Previous Close | 0.92 |
Day's Range | 0.85 - 0.94 |
52-Week Range | 0.73 - 11.18 |
Beta | 3.71 |
About GOVX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GOVX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for GOVX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-20.5%
GeoVax Labs shares are trading lower after multipl...
Unlock content with
Pro Subscription
1 month ago
+4.9%
GeoVax Labs shares are trading lower after the company announced it received a notification from Advanced Technology International to stop all work on its efforts with respect to Project Agreement No. 01; RRPV-24-04-NGVx-006; "NextGen Vaccinations: Phase 2B Clinical Trial Execution: Phase 2b study to evaluate GEO-CM04S1 COVID-19 vaccine"

1 month ago · https://thefly.com
GeoVax Labs price target lowered to $14 from $18 at D. Boral CapitalD. Boral Capital lowered the firm's price target on GeoVax Labs to $14 from $18 and keeps a Buy rating on the shares. GeoVax has encountered a significant challenge following the termination of its BA...